EATG » R&D

R&D

STEPS – HIV Cure Community Workshop in Glasgow – Final Report now out

On the 22nd of October, in Glasgow, the European AIDS Treatment Groups held the third edition of Steps – a community initiative to design the pathway to a long-term remission…

Community Cure Workshop Slides Now Online – Glasgow 2016

Organising the Community HIV Cure Workshop as a satellite event before the Glasgow HIV Drug Therapy Congress is a tradition already. This year's event, chaired by ECAB Chair Giulio Maria…

Petition to BRICS countries to triple funding for TB R&D

>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response. On 15 November 2016 over 200 petitioners from around the world asked Ministers of…

EPWG statement supporting recommendations of the UN High-Level Panel on Access to Medicines report

24 October 2016 We, Members of the European Parliament Working Group on innovation, access to medicines and poverty-related diseases (EPWG), would like to express our strong support for the findings…

Funding for TB research falls to lowest level in seven years

LIVERPOOL, UNITED KINGDOM, OCTOBER 25, 2016 —Tuberculosis (TB) killed 1.8 million people in 2015, making it the most deadly infectious disease worldwide, but funding for research into better TB prevention,…

A decade of flat funding could imperil progress of the HIV prevention research pipeline

Report released at HIV Research for Prevention Conference highlights funding trends, opportunities and challenges for HIV prevention R&D CHICAGO, Oct. 19, 2016 -- A new report released today at the second…

U.N. High Level Panel on Access to Medicines releases final report

United Nations Secretary-General’s High-Level Panel on Access to Medicines calls for new deal to close the health innovation and access gap The High-Level Panel on Access to Medicines released today…

MSF urges governments to set medical research policies that align with people’s health needs

New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs Geneva, 14 September, 2016 – Governments must do more…

GlaxoSmithKline Is Working on a Much Simpler HIV Treatment

While there have been quite a good number of patients on Tivicay® (dolutegravir) already, and some even see it as a revolutionary next step in treatment and the simplification of…

First review of EmERGE closed with positive opinion

The EATG has been working in the EmERGE project as the lead for the Dissemination and Popularisation Work Package. EmERGE will develop an mHealth (mobile health = health related services…